Linked Life Data

16935685

Source:http://linkedlifedata.com/resource/pubmed/id/16935685

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9537
pubmed:dateCreated
2006-8-28
pubmed:abstractText
The contributions of as-needed inhaled corticosteroids and long-acting beta2 agonists (LABA) to asthma control have not been fully established. We compared the efficacy and safety of three reliever strategies: a traditional short-acting beta2 agonist; a rapid-onset LABA (formoterol); and a combination of LABA and an inhaled corticosteroid (budesonide-formoterol) in symptomatic patients receiving budesonide-formoterol maintenance therapy.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1474-547X
pubmed:author
pubmed:issnType
Electronic
pubmed:day
26
pubmed:volume
368
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
744-53
pubmed:dateRevised
2007-5-15
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study.
pubmed:affiliation
Department of Pulmonology, University of Leiden, Leiden, Netherlands. K.F.Rabe@lumc.nl
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Multicenter Study